+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transaminase Test Market Size, Share & Trends Analysis Report by Test Type (ALT Test, AST Test, Combined Transaminase Panels), by Technology (Automated Analyzers, Semi-Automated & Manual Systems), by Application, by End Use, by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 6168242
REQUEST CUSTOMIZATION
Description Jump to:
The global transaminase test market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.81 billion by 2033, growing at a CAGR of 7.54% from 2025 to 2033. This market centers on rapid, accurate diagnostic platforms, such as AST (Aspartate Transaminase) and GOT (Glutamic Oxaloacetic Transaminase) assays, used extensively in liver function assessment, disease monitoring, and general health screening.

These platforms support timely clinical decisions, driven by increasing awareness of liver diseases and widespread integration into hospital, clinical, and point-of-care settings. The growth in the transaminase test industry is propelled by a combination of advancing technology and increasing access in emerging markets. Innovations in point-of-care AST/GOT devices-bolstered by AI-enabled interpretation-are reducing turnaround times and improving precision. Accessibility is expanding beyond well-resourced labs to outpatient clinics and rural settings, thanks to portable formats and software-driven automation.

Another major growth driver is the rising global burden of liver disease. The increasing prevalence of non-alcoholic fatty liver disease (NAFLD), viral hepatitis, and alcohol-related liver conditions underscores the need for regular transaminase screening. Coupled with aging populations and preventive health programs, demand is mounting for reliable, cost-effective liver biomarker tests.

In March 2025, the European Medicines Agency (EMA) approved the use of the artificial intelligence (AI) tool AIM-NASH in clinical trials to assess the severity of metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. Developed using machine learning, AIM-NASH was trained with over 100,000 annotations from 59 pathologists and evaluated more than 5,000 liver biopsies across nine large clinical trials. The EMA's human medicines committee confirmed that AIM-NASH can reliably determine disease activity from biopsies with less variability than the current standard, which typically relies on a consensus of three pathologists. This advancement is expected to enhance the clarity of evidence regarding the benefits of new treatments in clinical trials.

Overall, the global transaminase test market is experiencing significant transformation, driven by technological advancements and evolving healthcare needs. Integrating artificial intelligence (AI) into diagnostic platforms enhances the precision and efficiency of liver function assessments, enabling earlier detection and personalized treatment strategies. Point-of-care testing (POCT) expands access to liver diagnostics, particularly in remote and underserved regions, by providing rapid and convenient testing options. Furthermore, developing non-invasive diagnostic tools reduces reliance on traditional biopsy procedures, aligning with the growing preference for less invasive methods among patients and healthcare providers.

These innovations are improving patient outcomes and reshaping the competitive landscape, prompting key players to invest in research and development to stay at the forefront of the market. With the demand for efficient and accessible liver diagnostics continuing to rise, the market is well-positioned for sustained growth, offering opportunities for companies to leverage emerging technologies and meet the evolving needs of the global healthcare ecosystem.

Global Transaminase Test Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the transaminase test market on the basis of test type, technology, application, end use, and region:

Test Type Outlook (Revenue, USD Million, 2021-2033)

  • ALT Test
  • AST Test
  • Combined Transaminase Panels
  • Others

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Automated Analyzers
  • Semi-Automated & Manual Systems
  • Point-of-Care (POC) Devices
  • Paper-Based / Lab-on-a-Chip Platforms
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Liver Disease Diagnosis & Monitoring
  • Hepatitis Screening
  • Drug-Induced Liver Injury (DILI) Monitoring
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics
  • Diagnostic Laboratories (centralized testing)
  • Research Institutes
  • Home Testing
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Rising Prevalence of Liver Diseases
3.4.2. Advancements in Diagnostic Technologies
3.4.3. Expansion of Preventive Healthcare & Screening Programs
3.5. Market Restraint Analysis
3.5.1. Limited Awareness in Low-Income Regions
3.5.2. Cost & Infrastructure Barriers
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
3.6.2. Porter’s Five Forces Analysis
Chapter 4. Test Type Business Analysis
4.1. Transaminase Test Market: Test Type Movement Analysis
4.2. ALT Test
4.2.1. ALT Test Market, 2021-2033 (USD Million)
4.3. AST Test
4.3.1. AST Test Market, 2021-2033 (USD Million)
4.4. Combined Transaminase Panels
4.4.1. Combined Transaminase Panels Market, 2021-2033 (USD Million)
4.5. Others
4.5.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Transaminase Test Market: Technology Movement Analysis
5.2. Automated Analyzers
5.2.1. Automated Analyzers Market, 2021-2033 (USD Million)
5.3. Semi-Automated & Manual Systems
5.3.1. Semi-Automated & Manual Systems Market, 2021-2033 (USD Million)
5.4. Point-of-Care (POC) Devices
5.4.1. Point-of-Care (POC) Devices Market, 2021-2033 (USD Million)
5.5. Paper-Based / Lab-on-a-Chip Platforms
5.5.1. Paper-Based / Lab-on-a-Chip Platforms Market, 2021-2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Transaminase Test Market: Application Movement Analysis
6.2. Liver Disease Diagnosis & Monitoring
6.2.1. Liver Disease Diagnosis & Monitoring Market, 2021-2033 (USD Million)
6.3. Hepatitis Screening
6.3.1. Hepatitis Screening Market, 2021-2033 (USD Million)
6.4. Drug-Induced Liver Injury (DILI) Monitoring
6.5. Others
6.5.1. Others Market, 2021-2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. Transaminase Test Market: End Use Movement Analysis
7.2. Hospitals & Clinics
7.2.1. Hospitals & Clinics Market, 2021-2033 (USD Million)
7.3. Diagnostic Laboratories (centralized testing)
7.3.1. Diagnostic Laboratories (centralized testing) Market, 2021-2033 (USD Million)
7.4. Research Institutes
7.4.1. Research Institutes Market, 2021-2033 (USD Million)
7.5. Home Testing
7.5.1. Home Testing Market, 2021-2033 (USD Million)
7.6. Others
7.6.1. Others Market, 2021-2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Transaminase Test Market Share by Region, 2024 & 2033
8.2. North America
8.2.1. North America Transaminase Test market, 2021-2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Target Disease Prevalence
8.2.2.3. Competitive Scenario
8.2.2.4. Regulatory Framework
8.2.2.5. Reimbursement Scenario
8.2.2.6. U.S. Transaminase Test market, 2021-2033 (USD MILLION)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.3.6. Canada Transaminase Test market, 2021-2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Reimbursement Scenario
8.2.4.6. Mexico Transaminase Test market, 2021-2033 (USD Million)
8.3. Europe
8.3.1. Europe Transaminase Test market, 2021-2033 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Scenario
8.3.2.6. Germany Transaminase Test market, 2021-2033 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.3.6. UK Transaminase Test market, 2021-2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.4.6. France Transaminase Test market, 2021-2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.5.6. Italy Transaminase Test market, 2021-2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Spain Transaminase Test market, 2021-2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. Denmark Transaminase Test market, 2021-2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. Sweden Transaminase Test market, 2021-2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Norway Transaminase Test market, 2021-2033 (USD Million)
8.4. Asia-Pacific
8.4.1. Asia-Pacific Transaminase Test market, 2021-2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Scenario
8.4.2.6. Japan Transaminase Test market, 2021-2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.3.6. China Transaminase Test market, 2021-2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.4.4.6. India Transaminase Test market, 2021-2033 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Scenario
8.4.5.6. South Korea Transaminase Test market, 2021-2033 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. Australia Transaminase Test market, 2021-2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Reimbursement Scenario
8.4.7.6. Thailand Transaminase Test market, 2021-2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Transaminase Test market, 2021-2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Scenario
8.5.2.6. Brazil Transaminase Test market, 2021-2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.3.6. Argentina Transaminase Test market, 2021-2033 (USD Million)
8.6. MEA
8.6.1. MEA Transaminase Test market, 2021-2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. Regulatory Framework
8.6.2.5. Reimbursement Scenario
8.6.2.6. South Africa Transaminase Test market, 2021-2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Scenario
8.6.3.6. Saudi Arabia Transaminase Test market, 2021-2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Scenario
8.6.4.6. UAE Transaminase Test market, 2021-2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Scenario
8.6.5.6. Kuwait Transaminase Test market, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant’s overview
9.2. Financial performance
9.3. Participant categorization
9.3.1. Market Leaders
9.3.2. Transaminase Test Market Share Analysis, 2024
9.3.3. Company Profiles
9.3.3.1. F. Hoffmann-La Roche AG
9.3.3.1.1. Company Overview
9.3.3.1.2. Financial Performance
9.3.3.1.3. Product Benchmarking
9.3.3.1.4. Strategic Initiatives
9.3.3.2. Abbott
9.3.3.2.1. Company Overview
9.3.3.2.2. Financial Performance
9.3.3.2.3. Product Benchmarking
9.3.3.2.4. Strategic Initiatives
9.3.3.3. Thermo Fisher Scientific
9.3.3.3.1. Company Overview
9.3.3.3.2. Financial Performance
9.3.3.3.3. Product Benchmarking
9.3.3.3.4. Strategic Initiatives
9.3.3.4. Siemens Healthineers
9.3.3.4.1. Company Overview
9.3.3.4.2. Financial Performance
9.3.3.4.3. Product Benchmarking
9.3.3.4.4. Strategic Initiatives
9.3.3.5. Danaher
9.3.3.5.1. Company Overview
9.3.3.5.2. Financial Performance
9.3.3.5.3. Product Benchmarking
9.3.3.5.4. Strategic Initiatives
9.3.3.6. Randox Laboratories Ltd
9.3.3.6.1. Company Overview
9.3.3.6.2. Financial Performance
9.3.3.6.3. Product Benchmarking
9.3.3.6.4. Strategic Initiatives
9.3.3.7. ELITechGroup
9.3.3.7.1. Company Overview
9.3.3.7.2. Financial Performance
9.3.3.7.3. Product Benchmarking
9.3.3.7.4. Strategic Initiatives
9.3.3.8. Horiba Medical
9.3.3.8.1. Company Overview
9.3.3.8.2. Financial Performance
9.3.3.8.3. Product Benchmarking
9.3.3.8.4. Strategic Initiatives
9.3.3.9. Alpha Laboratories
9.3.3.9.1. Company Overview
9.3.3.9.2. Financial Performance
9.3.3.9.3. Product Benchmarking
9.3.3.9.4. Strategic Initiatives
9.3.3.10. Laboratory Corporation of America Holdings (LabCorp)
9.3.3.10.1. Company Overview
9.3.3.10.2. Financial Performance
9.3.3.10.3. Product Benchmarking
9.3.3.10.4. Strategic Initiatives
9.3.3.11. Bio-Rad Laboratories, Inc.
9.3.3.11.1. Company Overview
9.3.3.11.2. Financial Performance
9.3.3.11.3. Product Benchmarking
9.3.3.11.4. Strategic Initiatives
9.3.3.12. bioMérieux
9.3.3.12.1. Company Overview
9.3.3.12.2. Financial Performance
9.3.3.12.3. Product Benchmarking
9.3.3.12.4. Strategic Initiatives
9.3.4. Strategy Mapping
9.3.4.1. Expansion
9.3.4.2. Acquisition
9.3.4.3. Collaborations
9.3.4.4. Disease Type/Drug Class Launch
9.3.4.5. Partnerships
9.3.4.6. Others
List of Tables
TABLE 1 Transaminase Test Market- Industry Snapshot & Key Buying Criteria, 2021-2033
TABLE 2 Global Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 3 Global Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 4 Global Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 5 Global Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 6 Global Transaminase Test Market, by Region, 2021-2033 (USD Million)
TABLE 7 Transaminase Test- Key Market Driver Analysis
TABLE 8 Transaminase Test- Key Market Restraint Analysis
TABLE 9 North America Transaminase Test Market, by Country, 2021-2033 (USD Million)
TABLE 10 North America Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 11 North America Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 12 North America Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 13 North America Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 14 U.S. Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 15 U.S. Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 16 U.S. Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 17 U.S. Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 18 Canada Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 19 Canada Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 20 Canada Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 21 Canada Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 22 Mexico Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 23 Mexico Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 24 Mexico Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 25 Mexico Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 26 Europe Transaminase Test Market, by Country, 2021-2033 (USD Million)
TABLE 27 Europe Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 28 Europe Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 29 Europe Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 30 Europe Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 31 Germany Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 32 Germany Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 33 Germany Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 34 Germany Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 35 Uk Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 36 Uk Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 37 Uk Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 38 Uk Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 39 France Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 40 France Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 41 France Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 42 France Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 43 Italy Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 44 Italy Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 45 Italy Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 46 Italy Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 47 Spain Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 48 Spain Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 49 Spain Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 50 Spain Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 51 Denmark Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 52 Denmark Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 53 Denmark Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 54 Denmark Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 55 Sweden Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 56 Sweden Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 57 Sweden Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 58 Sweden Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 59 Norway Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 60 Norway Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 61 Norway Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 62 Norway Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 63 Asia-Pacific Transaminase Test Market, by Country, 2021-2033 (USD Million)
TABLE 64 Asia-Pacific Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 65 Asia-Pacific Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 66 Asia-Pacific Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 67 Asia-Pacific Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 68 Japan Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 69 Japan Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 70 Japan Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 71 Japan Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 72 China Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 73 China Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 74 China Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 75 China Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 76 India Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 77 India Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 78 India Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 79 India Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 80 Australia Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 81 Australia Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 82 Australia Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 83 Australia Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 84 South Korea Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 85 South Korea Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 86 South Korea Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 87 South Korea Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 88 Thailand Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 89 Thailand Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 90 Thailand Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 91 Thailand Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 92 Latin America Transaminase Test Market, by Country, 2021-2033 (USD Million)
TABLE 93 Latin America Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 94 Latin America Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 95 Latin America Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 96 Latin America Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 97 Brazil Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 98 Brazil Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 99 Brazil Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 100 Brazil Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 101 Argentina Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 102 Argentina Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 103 Argentina Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 104 Argentina Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 105 MEAMEA Transaminase Test Market, by Country, 2021-2033 (USD Million)
TABLE 106 MEA Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 107 MEA Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 108 MEA Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 109 MEA Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 110 South Africa Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 111 South Africa Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 112 South Africa Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 113 South Africa Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 114 Saudi Arabia Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 115 Saudi Arabia Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 116 Saudi Arabia Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 117 Saudi Arabia Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 118 UAE Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 119 UAE Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 120 UAE Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 121 UAE Transaminase Test Market, by End Use, 2021-2033 (USD Million)
TABLE 122 Kuwait Transaminase Test Market, by Test Type, 2021-2033 (USD Million)
TABLE 123 Kuwait Transaminase Test Market, by Technology, 2021-2033 (USD Million)
TABLE 124 Kuwait Transaminase Test Market, by Application, 2021-2033 (USD Million)
TABLE 125 Kuwait Transaminase Test Market, by End Use, 2021-2033 (USD Million)
List of Figures
FIG. 1 Transaminase Test Market Segmentation
FIG. 2 Global Transaminase Test Market, 2021-2033 (USD Million)
FIG. 3 Transaminase Test Market Dynamics
FIG. 4 Transaminase Test Market - Porter’s Analysis
FIG. 5 Transaminase Test Market - PESTEL Analysis
FIG. 6 Transaminase Test Revenue Share, by Test Type, 2024 & 2033
FIG. 7 ALT Test Market, 2021-2033 (USD Million)
FIG. 8 AST Test Market, 2021-2033 (USD Million)
FIG. 9 Combined Transaminase Panels Market, 2021-2033 (USD Million)
FIG. 10 Others Market, 2021-2033 (USD Million)
FIG. 11 Transaminase Test Revenue Share, by Technology, 2024 & 2033
FIG. 12 Automated Analyzers Market, 2021-2033 (USD Million)
FIG. 13 Semi-Automated & Manual Systems Market, 2021-2033 (USD Million)
FIG. 14 Point-of-Care (POC) Devices Market, 2021-2033 (USD Million)
FIG. 15 Paper-Based / Lab-on-a-Chip Platforms Market, 2021-2033 (USD Million)
FIG. 16 Others Market, 2021-2033 (USD Million) Market, 2021-2033 (USD Million)
FIG. 17 Transaminase Test Revenue Share, by Application, 2024 & 2033
FIG. 18 Liver Disease Diagnosis & Monitoring Market, 2021-2033 (USD Million)
FIG. 19 Hepatitis Screening Market, 2021-2033 (USD Million)
FIG. 20 Drug-Induced Liver Injury (DILI) Monitoring Market, 2021-2033 (USD Million)
FIG. 21 Others Market, 2021-2033 (USD Million) Market, 2021-2033 (USD Million)
FIG. 22 Transaminase Test Revenue Share, by End Use, 2024 & 2033
FIG. 23 Hospitals & Clinics Market, 2021-2033 (USD Million)
FIG. 24 Diagnostic Laboratories (centralized testing) Market, 2021-2033 (USD Million)
FIG. 25 Research Institutes Market, 2021-2033 (USD Million)
FIG. 26 Home testing Market, 2021-2033 (USD Million)
FIG. 27 Others Market, 2021-2033 (USD Million)
FIG. 28 Transaminase Test Revenue Share, by Region, 2024 & 2033
FIG. 29 North America Transaminase Test Market, 2021-2033 (USD Million)
FIG. 30 U.S. Transaminase Test Market, 2021-2033 (USD Million)
FIG. 31 Canada Transaminase Test Market, 2021-2033 (USD Million)
FIG. 32 Mexico Transaminase Test Market, 2021-2033 (USD Million)
FIG. 33 Europe Transaminase Test Market, 2021-2033 (USD Million)
FIG. 34 Germany Transaminase Test Market, 2021-2033 (USD Million)
FIG. 35 UK Transaminase Test Market, 2021-2033 (USD Million)
FIG. 36 France Transaminase Test Market, 2021-2033 (USD Million)
FIG. 37 Italy Transaminase Test Market, 2021-2033 (USD Million)
FIG. 38 Spain Transaminase Test Market, 2021-2033 (USD Million)
FIG. 39 Denmark Transaminase Test Market, 2021-2033 (USD Million)
FIG. 40 Sweden Transaminase Test Market, 2021-2033 (USD Million)
FIG. 41 Norway Transaminase Test Market, 2021-2033 (USD Million)
FIG. 42 Asia-Pacific Transaminase Test Market, 2021-2033 (USD Million)
FIG. 43 Japan Transaminase Test Market, 2021-2033 (USD Million)
FIG. 44 China Transaminase Test Market, 2021-2033 (USD Million)
FIG. 45 India Transaminase Test Market, 2021-2033 (USD Million)
FIG. 46 Australia Transaminase Test Market, 2021-2033 (USD Million)
FIG. 47 South Korea Transaminase Test Market, 2021-2033 (USD Million)
FIG. 48 Thailand Transaminase Test Market, 2021-2033 (USD Million)
FIG. 49 Latin America Transaminase Test Market, 2021-2033 (USD Million)
FIG. 50 Brazil Transaminase Test Market, 2021-2033 (USD Million)
FIG. 51 Argentina Transaminase Test Market, 2021-2033 (USD Million)
FIG. 52 MEA Transaminase Test Market, 2021-2033 (USD Million)
FIG. 53 South Africa Transaminase Test Market, 2021-2033 (USD Million)
FIG. 54 Saudi Arabia Transaminase Test Market, 2021-2033 (USD Million)
FIG. 55 UAE Transaminase Test Market, 2021-2033 (USD Million)
FIG. 56 Kuwait Transaminase Test Market, 2021-2033 (USD Million)

Companies Mentioned

The major companies profiled in this Transaminase Test market report include:
  • F. Hoffmann-La Roche AG
  • Abbott
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Danaher
  • Randox Laboratories Ltd
  • ELITechGroup
  • Horiba Medical
  • Alpha Laboratories
  • Laboratory Corporation of America Holdings (LabCorp)
  • Bio-Rad Laboratories, Inc.
  • bioMérieux

Table Information

Report AttributeDetails
No. of Pages150
PublishedAugust 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 4.1 Billion
Forecasted Market Value ( USD ) by 2033 $ 7.81 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

GABA Transaminase Inhibitor - Pipeline Insight, 2025 - Product Image

GABA Transaminase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Biocatalysis. Methods in Enzymology Volume 714 - Product Image

Biocatalysis. Methods in Enzymology Volume 714

  • Book
Diagnostic Enzymes Market Size, Share & Trends Analysis Report by Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product ( Molecular Enzymes, Clinical Enzymes), End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Diagnostic Enzymes Market Size, Share & Trends Analysis Report by Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product ( Molecular Enzymes, Clinical Enzymes), End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
U.S. Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kit and Reagents, Enzymes), By Application (Cloning, NGS, PCR), By End Use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kit and Reagents, Enzymes), By Application (Cloning, NGS, PCR), By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • 137 Pages
  • United States
From
Enzymes for Antibiotic Synthesis Market - Global Forecast 2025-2030 - Product Image

Enzymes for Antibiotic Synthesis Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.